When the third round finally began at 11 a.m., the Alexandre-Towards decided to see where he could be taken by the golf day. As a result, he drew up a solid 65 p.m., with a three-round achievement of 199 (68-66-65), lower than the standard 17 p.

“It is true that I have no strategy. I am only golf, and I wait for a final outcome. I have no strategy,” he said, “The fruits of today are good. I simply engulfed the taboo, but I am a man, and I cannot be too demanding. There is no rolling balloon, but you can directly attack each hole’s flag, because the balloons are quite soft.”

Alexandre-Towards achieved a victory in South Africa last year, although the winning competition was only co-certified by the European Challenge Circuit. The Sunday will be a completely new experience, as he will have to compete on the European cruise. “This is the first time that I have taken the lead. I want to see how I will be psychologically prepared. I now enjoy this feeling,” he said.

The South Africans selected Henri-Doplesis (Hennie Du Plessis), Sweden, Jokim Lagergren (Joakim Lagergren), Malaysia, Gavin Green (Gavin Green) and Germany, Nik-Bahm (Nick Bachem) at 200 p., below standard 16 p. and ranked second.

Yokin-Ragargren handed over 63 piles that were difficult to believe, and it was more remarkable that he had not lost one to nine small birds in the wet season. “I was very good today, especially my iron pole. Today, it is a different balloon, with a longer balloon, because the site is very humid. But I do not have taboos. I have no glimpse, “Swiss say.

Henry-Doples faculties captured five single birds, an old eagle, with no bare taboos and handing over 65 ples. Gwen-Green 7 shelled only two birds and shelled 67 ples. Nik-Bahm 4 shelled only one shell with 69 tiles.

Juen-Fedensen (Ewen Ferguson, 66 p.), Román-Rangask (Romain Langasque, 69 p.), Martin-Fusst (Martin Vorster, 68 p.) lagged behind two poles and was ranked sixth.

For the first time, Chinese men and women were promoted at the European cruise, while three small birds were captured on Saturdays, three barbers and one barbaric tabo, 74 poles, three rounds of 212 p. (70-68-74), less than standard 4 pole and 71 poles.

Chinese scientists have found signs of water activity on Mars.

On May 11, science progress published an important research result on Martian water activities. Based on the short wave infrared spectrum and navigation Terrain Camera data obtained by the Mars rover zhurong, Chinese researchers found a plate-shaped bright colored rock similar to sedimentary rock on the surface of Mars. Further analysis found that these plate-shaped bright colored rocks are rich in minerals such as water bearing sulfate.

This marks the first time that zhurong international has used the short wave infrared spectrometer on the rover to detect water bearing minerals in situ on Mars.

“The discovery of signs of water activity in the relatively young geological age landing area of zhurong indicates that the Martian hydrosphere during the Amazon period may be more active than previously thought. This discovery is of great significance to understand the evolution history of Martian climate and environment.” Liu Yang, the first author and corresponding author of the paper and researcher of the National Space Science Center of the Chinese Academy of Sciences, said.

The zhurong Mars rover carried by China’s first Mars exploration mission tianwen-1 successfully landed in the southern region of Utopia plain on May 15, 2021. Up to now, the Mars rover zhurong has been traveling in the utopian plain in the northern lowlands of Mars for one year, with a total of nearly 2000 meters, and has obtained a large number of valuable scientific exploration data.

The existing dating work of the impact crater shows that the landing area of the Mars rover zhurong is located in the Amazon stratum after the later reconstruction event. During the Amazon period, the climate of Mars has changed from warm and humid to cold and dry. The analysis of orbital remote sensing data shows that a variety of geomorphic features distributed around the landing site indicate that there may have been a large amount of volatile matter in the utopian plain.

However, “limited by the spatial resolution and coverage, the orbital remote sensing data did not find water bearing minerals near the landing area, which brings many questions about the formation mechanism of such landforms and the nature of water activities in the area.” Liu Yang said.

The research team believes that the plate-shaped bright colored rock found by zhurong is a hard shell developed locally in the landing area. Compared with the broken rocks observed in situ by the American pirate 1 Mars Lander, the hard shell in the zhurong landing area seems to be more erosion resistant, and the hard shell layer is relatively thick.

“Forming such a thick hard shell requires a lot of liquid water, which cannot be formed only by water vapor in the atmosphere.” Liu Yang explained.

At the same time, the study found that there was no obvious surface runoff or river trace in the landing area, and no fluffy surface and salt frost residues formed by water evaporation were found around the inspection route, which ruled out the possibility of large-scale water activities on the surface of the landing area.

In this regard, the research team proposed a new formation mechanism. This mechanism suggests that the soil weathering layer before the Martian sedimentary period experienced cementation and diagenesis during the rise or infiltration of salt rich groundwater, forming the observed tabular rocks. Salt cements precipitate in capillary pores or groundwater near the water table, and active evaporation and accumulation occur. The intermittent fluctuation of groundwater level may further thicken the hard shell and form layered structure. Subsequently, the topsoil covered on the hard shell is eroded away, exposing the erosion resistant hard shell layer.

Liu Yang said that the discovery of the zhurong Rover showed that the water activity of Mars during the Amazon period may be more active than previously thought. The zhurong landing area and the extensive area of the northern plains of Mars may contain a large amount of available water in the form of hydrous minerals.

Reviewed by: Yue Liang

Nail officials did not comment on the news.

According to people close to nailing, there are indeed organizational optimization actions inside, but there is a big gap with the proportion exposed on social platforms. This is not a massive layoff, but the company’s routine fiscal year performance appraisal replacement and business adjustment, with an overall adjustment ratio of less than 10%.

Wuliangye fell 5% and its share price hit a new low since June 2020, more than 50% lower than the peak in February last year.

In March 7th, the Baijiu plate fell. As of press time, Luzhou Laojiao and Wuliangye had fallen by nearly 5%, Kouzijiao by 4.48%, Guizhou Maotai by 3.02% and Shanxi Fenjiu by 2.19%. The entire sector index fell 3.52%, ranking at the top of the decline list.

Among them, Wuliangye fell 5%, and its share price hit a new low since June 2020, with a decline of more than 50% compared with the peak in February last year.

CICC believes that the fundamentals are stable in the off-season, the pessimistic risk aversion triggered the plate adjustment, and the current valuation layout is cost-effective. Although there is downward pressure on the short-term economy, the fundamentals of Baijiu plate remain stable and continue to be structural prosperity. Among them, the business margin of high-end leaders is improving, the product structure of Maotai is continuously improved, and the marketing reform is advancing steadily. It is expected that the performance growth is expected to accelerate in 2022; The personnel adjustment of Wuliangye has been gradually completed (announced on February 18). It is expected that the follow-up volume and price strategy will be more clear and definite, and the general five approval price is expected to stabilize and rise; Laojiao’s performance is expected to accelerate under the empowerment of equity incentive.

CITIC believes that the overall valuation has been in the range of cost-effective, and some of the Baijiu valuation has dropped to even below the 2019 level. In the short term, the current epidemic still has a dynamic sales impact on some markets. It is expected that the overall dynamic sales will remain stable and weak in the short term of 1-2 months. There is still pressure on the delivery of wine enterprises and the transmission and landing of price increase of mainstream single products. At the same time, there are repeated outflows and inflows from the north, but some investors have expected at present. In the present era, we should also go beyond the short-term macro distance and look at Baijiu investment based on the long cycle. We should grasp the overall upgrading and optimization of the whole industry and the differentiation and growth stages of the stocks, and some high-quality leading enterprises have already entered the bottom area, with a long term and better yield base.

Shareholder welfare is coming! Send you ten gold stocks! Click View > >

February 28, 2022 is the 15th “international day of rare diseases”. In the world, there are more than 7000 known rare diseases, and there are about 20 million patients with rare diseases in China. For a long time, some rare disease groups lack social attention. They become friends and keep warm together.

Treatment drugs are expensive or lack of effective treatment, which also makes the survival of patients with rare diseases face difficulties. At present, there are more than 50 kinds of drugs for rare diseases listed in China, of which more than 40 kinds have been included in the national medical insurance drug catalogue. At present, some drugs for rare diseases, which are particularly expensive, cannot be included in the payment scope of basic medical insurance.

Caring for patients with rare diseases still needs the continuous attention and efforts of all social forces.

It all started with a small wound. At the beginning of 2020, in Urumqi, Xinjiang, Yan Li’s two-year-old son fell and broke his lip. The family took the little boy to the hospital for simple treatment of the wound, but it stopped bleeding about a week later.

After running to three hospitals, Yan Li finally got the answer at the Beijing Children’s Hospital Affiliated to Capital Medical University. The activated partial thromboplastin time (APTT) test showed that the activity level of coagulation factor Ⅷ in Yan Li’s son was only about 1%, while that in healthy people was more than 40%. The doctor diagnosed his son with severe hemophilia type A.

This is the first time Yan Li has heard of hemophilia. This is a genetic disease that causes abnormal bleeding in healthy people due to the lack of coagulation factors in the body. Hemophilia patients are also known as “glass people”. Once they get sick, even a small wound can be fatal.

On May 11, 2018, hemophilia was included in the catalogue of the first batch of rare diseases jointly formulated by the National Health Commission and other five departments.

Guan Tao, head of Beijing hemophilia home rare disease care center (hereinafter referred to as hemophilia home), introduced that in recent years, with the improvement of medical insurance and drug supply, the treatment awareness and situation of hemophilia patients in China have been improved. “At present, there are differences in the reimbursement proportion and amount of hemophilia in different regions. Most regions have an upper limit for reimbursement, the amount is about 150000-200000, and the average reimbursement proportion is 70% - 80%.” Guan Tao said.

However, for some hemophilia patients, the treatment is still difficult. A new drug approved in 2018, emcezumab injection (hereinafter referred to as emcezumab) provides hope for antibody patients, but its high cost discourages them.

On February 21, the family of blood friends sent an open letter. In this open letter, the family of blood friends called on Roche pharmaceutical, the manufacturer of Amy Saizhu, to reduce the price as soon as possible and strive to be included in medical insurance. Guan Tao told surging news (www.thepaper. CN) that there are complex factors affecting whether to enter medical insurance, but the blood friends home sent this letter in the hope that it can play a role in promoting.

Wu Min and her son are together. The interviewee provides the picture

From on demand to prevention

In Wuhan, Hubei Province, the Wu Min family has been fighting hemophilia for more than four years. In the second half of 2017, Wu Min’s one year old son went to the hospital because of diarrhea. The nurse drew blood from his neck. Within a few hours, his neck was swollen. The next day, the son even had some difficulty eating.

Wu Min took her son to Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of science and technology. It was found that the activity level of coagulation factor Ⅷ of her son was only 0.4%, which was diagnosed as severe hemophilia type A.

Hemophilia is an X-linked recessive hemorrhagic disease, which is divided into hemophilia type A and hemophilia type B. The former is a lack of coagulation factor VIII (F VIII), with an incidence rate of 1/5000, while the latter is a lack of coagulation factor IX (F IX), with an incidence rate of 1/25000. According to statistics, there are about 136000 hemophiliacs in China. Among all hemophilia patients, hemophilia type A patients account for 80% ~ 85%.

Hemophilia patients are called “glass people”, because of coagulation defects, a little wound can be fatal. The main clinical manifestations are bleeding of joints, muscles and deep tissues, as well as bleeding of internal organs such as gastrointestinal tract and central nervous system.

Looking back on her son’s birth, Wu Min didn’t notice the difference between her son and ordinary children. The only clue is that when his son was a hundred days old, he fell off the sofa and hit his forehead on the chair. It took him more than two weeks to recover. “We didn’t think about this at that time.” Wu Min said.

According to public information, the treatment of hemophilia is mainly based on alternative treatment. Generally, there are two ideas. One is on-demand treatment, which refers to the treatment when the patient has obvious bleeding. The purpose is to stop bleeding in time, but it can not prevent the occurrence of joint disability caused by repeated bleeding in patients with severe hemophilia. The more ideal way is preventive treatment, which is a regular treatment given regularly (2 to 3 times a week) to prevent bleeding, with the goal of maintaining the patient’s normal joint and muscle function.

Due to the lack of certain coagulation factors in the body, patients need to supplement factors with drugs to improve coagulation function. For patients with hemophilia type A, intravenous injection of gene recombinant f Ⅷ preparation or virus inactivated blood derived f Ⅷ preparation is commonly used, which is called coagulation factor 8 by patients. For hemophilia B, gene recombinant f IX preparation or virus inactivated blood derived prothrombin complex can be selected.

Guan Tao, head of Beijing hemophilia home rare disease care center, introduced that in recent years, with the improvement of medical insurance and drug supply, the treatment awareness and current situation of hemophilia patients in China have been optimized.

“At present, there are differences in the reimbursement proportion and amount of hemophilia in different regions. Most regions have an upper limit for reimbursement, the amount is about 150000-200000, and the average reimbursement proportion is 70% - 80%.” Guan Tao introduced that at present, the proportion of domestic hemophilia patients using on-demand treatment and preventive treatment accounts for about 50% respectively, but at present, most domestic preventive treatment is low-dose. In European and American developed countries, medium and high-dose preventive treatment is often used.

A foreign study in 2004 showed that the average cost of treating severe hemophilia in developed countries is US $139000 per person per year (about 88000 yuan), and the minimum cost of on-demand treatment to ensure life is US $48000 per person (about 300000 yuan). In developed countries, the quality of life of patients with hemophilia can reach a level similar to that of normal people.

Children’s Hospital Affiliated to Chongqing Medical University